Bebtelovimab (LY-CoV1404) neutralizes Omicron, including the subvariant BA.2, as demonstrated by pseudovirus and/or authentic virus data Previously reported data show that bebtelovimab has broad and potent neutralization of all other… Read More
WHO’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countries Since the beginning of the pandemic, more than one… Read More
Facility strategically placed to enhance supply chain security and agility for customers RADNOR, P.A. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in… Read More
Bebtelovimab neutralizes Omicron, including subvariant BA.2, as demonstrated by pseudovirus and/or authentic virus data VANCOUVER, B.C. — AbCellera (Nasdaq: ABCL) today announced Eli Lilly and Company (Lilly) has entered into a… Read More
“Feedback from Canadian biotech companies on the contribution of young workers has been overwhelmingly positive. The Catalyst Award is our way to highlight new hires, showcase their achievements and tell… Read More
